Fresenius
Akorn CEO resigns after $4.3bn Fresenius deal falls through
December 10, 2018Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics
The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …
Top Ten most popular articles on Pharmafile.com this week
April 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, Fresenius, Shire, Takeda, arthritis, pharma
The year seems like it’s running away as we come to the end of April. It’s been a more tense …
Fresenius confirms takeover talks with Akorn
April 10, 2017Sales and Marketing Akorn, Fresenius
Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a view …
Abbott buys Russian firm Veropharm
December 15, 2014Manufacturing and Production, Sales and Marketing Abbott, Fresenius, cfr pharma, petrovax, sistema, veropharm, zenitco
Abbott has completed its purchase of Russia-based Veropharm in a $305 million deal as it looks to firmly establish itself …
FDA warns Fresenius Kabi over plant problems
August 27, 2013Manufacturing and Production FDA, Fresenius, kabi, recall
German drugmaker Fresenius has been sent another warning letter by the US Food and Drug Administration, this time for a …
Glass contamination prompts Fresenius recall
July 4, 2013Manufacturing and Production Fresenius, recall
The US subsidiary of German drugmaker Fresenius has recalled a drug used in the treatment of Parkinson’s disease because of …
